New trial shows nasal spray reduces infection of COVID-causing virus by 62%
A new clinical trial led by Queen Mary University of London and Barts Health researchers has shown that the pHOXWELL nasal spray can reduce infection with SARS-CoV-2—the virus that causes COVID-19—by 62%. The research ...
Aug 1, 2022
0
25